共 50 条
- [1] Refractory juvenile dermatomyositis: Response to tofacitinib MEDICINA CLINICA, 2022, 158 (02): : 95 - 96
- [6] Good Response to Tofacitinib in Refractory Amyopathic Dermatomyositis ACTAS DERMO-SIFILIOGRAFICAS, 2021, 112 (04): : 374 - 376
- [10] Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China Arthritis Research & Therapy, 25